In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic, naijapreneur™ reported.
SARS-CoV-2 causes this contagious illness, which triggers symptoms from a fever and dry cough to severe breathing difficulties within fourteen days of exposure.
Patients face varying degrees of severity after infection. At least a third of infected individuals show no noticeable symptoms at all.
Among those who do fall ill, 81 percent experience mild to moderate cases up to mild pneumonia.
More severe outcomes strike a smaller fraction of patients. Fourteen percent develop dyspnea, hypoxia, or significant lung involvement, while 5 percent face critical respiratory failure or shock. Older adults run the highest risk of severe illness and death.
Transmission happens when people breathe in infectious particles or touch contaminated surfaces before touching their faces. Small airborne particles remain suspended in indoor air over long distances, raising infection risks in close spaces.
Healthcare providers detect viral nucleic acid through several established methods.
Nasopharyngeal swabs undergo real-time reverse transcription polymerase chain reaction, transcription-mediated amplification, or RT-LAMP testing.
Infected individuals remain contagious for up to 20 days. Asymptomatic carriers can spread the virus without ever knowing they are sick.
Mass vaccination campaigns deployed approved vaccines across numerous countries to curb infection rates. Additional protective steps include social distancing, quarantining, and indoor ventilation.
Public health guidance urges people to wear face masks, wash hands frequently, and keep unwashed hands away from the face.
Medical providers rely primarily on supportive care, isolation, and experimental measures to manage active infections.
Some patients suffer from long COVID, enduring organ damage and lingering symptoms for months or years. Researchers continue multi-year studies tracking these long-term effects.